Active 0 6 0 6 B-chronic_disease
lupus 7 12 7 12 I-chronic_disease
nephritis 13 22 13 22 I-chronic_disease

Age 0 3 23 26 B-age
â‰¥ 4 5 27 28 O
16 6 8 29 31 B-lower_bound
years 9 14 32 37 I-lower_bound

Diagnosis 0 9 38 47 O
of 10 12 48 50 O
Systemic 13 21 51 59 B-chronic_disease
Lupus 22 27 60 65 I-chronic_disease
Erythematosus 28 41 66 79 I-chronic_disease
( 42 43 80 81 I-chronic_disease
SLE 43 46 81 84 I-chronic_disease
) 46 47 84 85 I-chronic_disease
by 48 50 86 88 O
American 51 59 89 97 O
College 60 67 98 105 O
of 68 70 106 108 O
Rheumatology 71 83 109 121 O
( 84 85 122 123 O
ACR)/SLICC 85 95 123 133 O
criteria 96 104 134 142 O

End 0 3 143 146 B-chronic_disease
- 3 4 146 147 I-chronic_disease
stage 4 9 147 152 I-chronic_disease
renal 10 15 153 158 I-chronic_disease
disease 16 23 159 166 I-chronic_disease
( 24 25 167 168 O
estimated 25 34 168 177 B-clinical_variable
GFR 35 38 178 181 I-clinical_variable
clearance 39 48 182 191 I-clinical_variable
< 49 50 192 193 O
20 51 53 194 196 B-upper_bound
mL 54 56 197 199 I-upper_bound
/ 56 57 199 200 I-upper_bound
min/1.73 57 65 200 208 I-upper_bound
m2 66 68 209 211 I-upper_bound
) 68 69 211 212 O

Greater 0 7 213 220 O
than 8 12 221 225 O
or 13 15 226 228 O
equal 16 21 229 234 O
to 22 24 235 237 O
5 25 26 238 239 B-lower_bound
times 27 32 240 245 I-lower_bound
the 33 36 246 249 I-lower_bound
upper 37 42 250 255 I-lower_bound
limit 43 48 256 261 I-lower_bound
of 49 51 262 264 I-lower_bound
normal 52 58 265 271 I-lower_bound
of 59 61 272 274 O
liver 62 67 275 280 O
function 68 76 281 289 O
tests 77 82 290 295 O
( 83 84 296 297 O
aspartate 84 93 297 306 O
aminotransferase 94 110 307 323 O
[ 111 112 324 325 O
AST 112 115 325 328 O
] 115 116 328 329 O
, 116 117 329 330 O
alanine 118 125 331 338 O
aminotransferase 126 142 339 355 O
[ 143 144 356 357 O
ALT 144 147 357 360 O
] 147 148 360 361 O
, 148 149 361 362 O
or 150 152 363 365 O
alkaline 153 161 366 374 O
phosphatase 162 173 375 386 O
) 173 174 386 387 O

History 0 7 388 395 O
of 8 10 396 398 O
cancer 11 17 399 405 B-cancer
, 17 18 405 406 O
except 19 25 407 413 O
carcinoma 26 35 414 423 B-cancer
in 36 38 424 426 I-cancer
situ 39 43 427 431 I-cancer
and 44 47 432 435 O
treated 48 55 436 443 O
basal 56 61 444 449 B-cancer
and 62 65 450 453 O
squamous 66 74 454 462 B-cancer
cell 75 79 463 467 I-cancer
carcinomas 80 90 468 478 I-cancer

Kidney 0 6 479 485 B-treatment
biopsy 7 13 486 492 I-treatment
documentation 14 27 493 506 O
of 28 30 507 509 O
International 31 44 510 523 B-clinical_variable
Society 45 52 524 531 I-clinical_variable
of 53 55 532 534 I-clinical_variable
Nephrology 56 66 535 545 I-clinical_variable
/ 66 67 545 546 I-clinical_variable
Renal 67 72 546 551 I-clinical_variable
Pathology 73 82 552 561 I-clinical_variable
Society 83 90 562 569 I-clinical_variable
( 91 92 570 571 I-clinical_variable
ISN 92 95 571 574 I-clinical_variable
/ 95 96 574 575 I-clinical_variable
RPS 96 99 575 578 I-clinical_variable
) 99 100 578 579 I-clinical_variable
Class 101 106 580 585 B-lower_bound
III 107 110 586 589 I-lower_bound
or 111 113 590 592 O
Class 114 119 593 598 B-upper_bound
IV 120 122 599 601 I-upper_bound
proliferative 123 136 602 615 O
nephritis 137 146 616 625 B-chronic_disease
( 147 148 626 627 O
including 148 157 627 636 O
Class 158 163 637 642 O
V 164 165 643 644 O
occurring 166 175 645 654 O
in 176 178 655 657 O
combination 179 190 658 669 O
with 191 195 670 674 O
Class 196 201 675 680 O
III 202 205 681 684 O
or 206 208 685 687 O
IV 209 211 688 690 O
) 211 212 690 691 O
within 213 219 692 698 O
12 220 222 699 701 B-lower_bound
months 223 229 702 708 I-upper_bound
and 230 233 709 712 O
a 234 235 713 714 O
urine 236 241 715 720 B-clinical_variable
protein 242 249 721 728 I-clinical_variable
/ 249 250 728 729 I-clinical_variable
creatinine 250 260 729 739 I-clinical_variable
ratio 261 266 740 745 I-clinical_variable
> 267 268 746 747 O
1 268 269 747 748 O
at 270 272 749 751 O
time 273 277 752 756 O
of 278 280 757 759 O
entry 281 286 760 765 O
to 287 289 766 768 O
study 290 295 769 774 O

Known 0 5 775 780 O
human 6 11 781 786 B-chronic_disease
immunodeficiency 12 28 787 803 I-chronic_disease
virus 29 34 804 809 I-chronic_disease
( 35 36 810 811 I-chronic_disease
HIV 36 39 811 814 I-chronic_disease
) 39 40 814 815 I-chronic_disease
and 41 44 816 819 O
hepatitis 45 54 820 829 B-chronic_disease
B 55 56 830 831 I-chronic_disease
or 57 59 832 834 I-chronic_disease
C 60 61 835 836 I-chronic_disease

Moderately 0 10 837 847 O
severe 11 17 848 854 O
anemia 18 24 855 861 B-chronic_disease
( 25 26 862 863 O
Hgb 26 29 863 866 B-clinical_variable
< 30 31 867 868 O
8 32 33 869 870 B-upper_bound
mg 34 36 871 873 I-upper_bound
/ 36 37 873 874 I-upper_bound
dL 37 39 874 876 I-upper_bound
) 39 40 876 877 O

Neutropenia 0 11 878 889 B-clinical_variable
( 12 13 890 891 O
< 13 14 891 892 O
1,000 15 20 893 898 B-upper_bound
/ 20 21 898 899 I-upper_bound
mm3 21 24 899 902 I-upper_bound
) 24 25 902 903 O

Positive 0 8 904 912 O
purified 9 17 913 921 B-clinical_variable
protein 18 25 922 929 I-clinical_variable
derivative 26 36 930 940 I-clinical_variable
( 37 38 941 942 I-clinical_variable
PPD 38 41 942 945 I-clinical_variable
) 41 42 945 946 I-clinical_variable
test 43 47 947 951 O
confirmed 48 57 952 961 O
by 58 60 962 964 O
positive 61 69 965 973 O
Quantiferon 70 81 974 985 B-clinical_variable
TB 82 84 986 988 I-clinical_variable
gold 85 89 989 993 I-clinical_variable

Pregnancy 0 9 994 1003 B-pregnancy

Pulmonary 0 9 1004 1013 O
fibrotic 10 18 1014 1022 O
changes 19 26 1023 1030 O
on 27 29 1031 1033 O
chest 30 35 1034 1039 B-treatment
radiograph 36 46 1040 1050 I-treatment
consistent 47 57 1051 1061 O
with 58 62 1062 1066 O
prior 63 68 1067 1072 O
healed 69 75 1073 1079 O
tuberculosis 76 88 1080 1092 B-chronic_disease

Severe 0 6 1093 1099 O
, 6 7 1099 1100 O
progressive 8 19 1101 1112 O
, 19 20 1112 1113 O
or 21 23 1114 1116 O
uncontrolled 24 36 1117 1129 O
renal 37 42 1130 1135 B-chronic_disease
, 42 43 1135 1136 O
hepatic 44 51 1137 1144 B-chronic_disease
, 51 52 1144 1145 O
hematological 53 66 1146 1159 B-chronic_disease
, 66 67 1159 1160 O
gastrointestinal 68 84 1161 1177 B-chronic_disease
, 84 85 1177 1178 O
pulmonary 86 95 1179 1188 B-chronic_disease
, 95 96 1188 1189 O
cardiac 97 104 1190 1197 B-chronic_disease
, 104 105 1197 1198 O
or 106 108 1199 1201 O
neurological 109 121 1202 1214 B-chronic_disease
disease 122 129 1215 1222 I-chronic_disease
( 130 131 1223 1224 O
or 131 133 1224 1226 O
, 133 134 1226 1227 O
in 135 137 1228 1230 O
the 138 141 1231 1234 O
investigator 142 154 1235 1247 O
's 154 156 1247 1249 O
opinion 157 164 1250 1257 O
, 164 165 1257 1258 O
any 166 169 1259 1262 O
other 170 175 1263 1268 O
concomitant 176 187 1269 1280 O
medical 188 195 1281 1288 O
condition 196 205 1289 1298 O
that 206 210 1299 1303 O
places 211 217 1304 1310 O
the 218 221 1311 1314 O
participant 222 233 1315 1326 O
at 234 236 1327 1329 O
risk 237 241 1330 1334 O
by 242 244 1335 1337 O
participating 245 258 1338 1351 O
in 259 261 1352 1354 O
this 262 266 1355 1359 O
study 267 272 1360 1365 O
) 272 273 1365 1366 O
with 274 278 1367 1371 O
the 279 282 1372 1375 O
exception 283 292 1376 1385 O
of 293 295 1386 1388 O
diseases 296 304 1389 1397 O
or 305 307 1398 1400 O
conditions 308 318 1401 1411 O
related 319 326 1412 1419 O
to 327 329 1420 1422 O
active 330 336 1423 1429 O
SLE 337 340 1430 1433 B-chronic_disease

Thrombocytopenia 0 16 1434 1450 B-chronic_disease
( 17 18 1451 1452 O
platelets 18 27 1452 1461 B-clinical_variable
< 28 29 1462 1463 O
50,000 30 36 1464 1470 B-upper_bound
/ 36 37 1470 1471 I-upper_bound
mm3 37 40 1471 1474 I-upper_bound
) 40 41 1474 1475 O

Unwillingness 0 13 1476 1489 B-contraception_consent
to 14 16 1490 1492 I-contraception_consent
use 17 20 1493 1496 I-contraception_consent
a 21 22 1497 1498 I-contraception_consent
medically 23 32 1499 1508 I-contraception_consent
acceptable 33 43 1509 1519 I-contraception_consent
form 44 48 1520 1524 I-contraception_consent
of 49 51 1525 1527 I-contraception_consent
birth 52 57 1528 1533 I-contraception_consent
control 58 65 1534 1541 I-contraception_consent
( 66 67 1542 1543 O
including 67 76 1543 1552 O
but 77 80 1553 1556 O
not 81 84 1557 1560 O
limited 85 92 1561 1568 O
to 93 95 1569 1571 O
a 96 97 1572 1573 O
diaphragm 98 107 1574 1583 B-contraception_consent
, 107 108 1583 1584 O
an 109 111 1585 1587 O
intrauterine 112 124 1588 1600 B-contraception_consent
device 125 131 1601 1607 I-contraception_consent
, 131 132 1607 1608 O
progesterone 133 145 1609 1621 B-contraception_consent
implants 146 154 1622 1630 I-contraception_consent
or 155 157 1631 1633 I-contraception_consent
injections 158 168 1634 1644 I-contraception_consent
, 168 169 1644 1645 O
oral 170 174 1646 1650 B-contraception_consent
contraceptives 175 189 1651 1665 I-contraception_consent
, 189 190 1665 1666 O
the 191 194 1667 1670 O
double 195 201 1671 1677 B-contraception_consent
- 201 202 1677 1678 I-contraception_consent
barrier 202 209 1678 1685 I-contraception_consent
method 210 216 1686 1692 I-contraception_consent
, 216 217 1692 1693 O
or 218 220 1694 1696 O
a 221 222 1697 1698 O
condom 223 229 1699 1705 B-contraception_consent
) 229 230 1705 1706 O

Use 0 3 1707 1710 O
of 4 6 1711 1713 O
experimental 7 19 1714 1726 B-treatment
therapeutic 20 31 1727 1738 I-treatment
agents 32 38 1739 1745 I-treatment
within 39 45 1746 1752 O
the 46 49 1753 1756 O
past 50 54 1757 1761 B-upper_bound
60 55 57 1762 1764 I-upper_bound
days 58 62 1765 1769 I-upper_bound

Use 0 3 1770 1773 O
of 4 6 1774 1776 O
rituximab 7 16 1777 1786 B-treatment
within 17 23 1787 1793 O
the 24 27 1794 1797 O
past 28 32 1798 1802 O
year 33 37 1803 1807 O

